synthetic biotic medicine (Synlogic)

N/A

Report date: 2025/01/26 16:24:36

Base Information

Drug Namesynthetic biotic medicine (Synlogic)
Drug Alias NameEcN-hIL-22inflammation therapy (Synlogic)microbiome modulator (Synlogic)inflammatory bowel disease therapy (Synolgic)
ClassificationBiologics
Mechanisms of ActionMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsInflammationInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynlogic Inc
China Registration ClassN/A

Develop Information

Active CompaniesSynlogic Inc
Inactive CompaniesAbbvie Inc
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A